Correlation Between Alzamend Neuro and Compania

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Alzamend Neuro and Compania at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alzamend Neuro and Compania into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alzamend Neuro and Compania De Minas, you can compare the effects of market volatilities on Alzamend Neuro and Compania and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alzamend Neuro with a short position of Compania. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alzamend Neuro and Compania.

Diversification Opportunities for Alzamend Neuro and Compania

0.57
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Alzamend and Compania is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Alzamend Neuro and Compania De Minas in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Compania De Minas and Alzamend Neuro is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alzamend Neuro are associated (or correlated) with Compania. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Compania De Minas has no effect on the direction of Alzamend Neuro i.e., Alzamend Neuro and Compania go up and down completely randomly.

Pair Corralation between Alzamend Neuro and Compania

Given the investment horizon of 90 days Alzamend Neuro is expected to generate 3.58 times more return on investment than Compania. However, Alzamend Neuro is 3.58 times more volatile than Compania De Minas. It trades about 0.09 of its potential returns per unit of risk. Compania De Minas is currently generating about 0.14 per unit of risk. If you would invest  91.00  in Alzamend Neuro on December 30, 2023 and sell it today you would earn a total of  9.00  from holding Alzamend Neuro or generate 9.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Alzamend Neuro  vs.  Compania De Minas

 Performance 
       Timeline  
Alzamend Neuro 

Risk-Adjusted Performance

3 of 100

 
Low
 
High
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Alzamend Neuro are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile basic indicators, Alzamend Neuro displayed solid returns over the last few months and may actually be approaching a breakup point.
Compania De Minas 

Risk-Adjusted Performance

5 of 100

 
Low
 
High
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Compania De Minas are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Compania may actually be approaching a critical reversion point that can send shares even higher in April 2024.

Alzamend Neuro and Compania Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Alzamend Neuro and Compania

The main advantage of trading using opposite Alzamend Neuro and Compania positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alzamend Neuro position performs unexpectedly, Compania can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compania will offset losses from the drop in Compania's long position.
The idea behind Alzamend Neuro and Compania De Minas pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Fundamental Analysis
View fundamental data based on most recent published financial statements